Oct, 1, 2023

Vol.30 No.2, pp. 84-88

Current Issue Archives
Search
Advanced Search
Editorial Office

Review

  • Korean Journal of Biological Psychiatry
  • Volume 13(4); 2006
  • Article

Review

Korean Journal of Biological Psychiatry 2006;13(4):299-304. Published online: Apr, 1, 2006

Abstract PDF Full Text

Association Study between Tic Disorder and Dopamine D2 Receptor Gene Polymorphism in Korean Population

  • Soyoung Irene Lee, MD, PhD1;In Hee Cho, MD, PhD2;Seon Mee Kim, MD, PhD3;Min-Soo Lee, MD, PhD4; and Han-Yong Jung, MD, PhD1;
    1;Department of Psychiatry, College of Medicine Soonchunhyang University, Bucheon Hospital, Bucheon, 2;Department of Psychiatry, Gachon University of Medicine and Science, Incheon, 3;Department of Family Medicine, College of Medicine Korea University, Guro Hospital, Seoul, 4;Department of Psychiatry, College of Medicine Korea University, Anam Hospital, Seoul, Korea
Abstract

Objectives：The purpose of the present study was to investigate whether the Taq I A polymorphism of dopamine receptor D2 gene(DRD2) is associated with Tourette syndrome(TS) and chronic motor tic disorder(CMT) in Korean population.

Methods：DRD2 Taq I A RFLP genotyping was carried out with DNA extracted from blood samples of 75 patients with tic disorders(47 with TS and 28 with CMT) and 90 healthy subjects. Genotype and allelic frequencies for the DRD2 gene polymorphisms of the tic disorder group as a whole were compared to those of the control group. Separating the TS group, thereafter, the frequency of genotypes and alleles were compared to those of the controls.

Results：The results demonstrated that genotype and allele distributions for the DRD2 gene polymorphism in the tic disorder as a whole, TS, and control groups were not significantly different.

Conclusion：No association was found for DRD2 gene, TS and CMT. The data suggest that DRD2 gene may not be a useful marker for the prediction of the susceptibility of tic disorder.

Keywords Tourette syndrome;Chronic motor tic disorder;Gene polymorphism;Receptors, dopamine D2;<i>Taq</i> I RFLP.